Clinical Trial Update: Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing standard Temozolomide alone to standard Temozolomide with early postoperative Temozolomide in newly diagnosed glioblastoma multiforme …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodal (temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glioblastoma | Phase 4 | Status: COMPLETED | Results posted: 2013-04-04